Discordant findings were for one HER2 3+ tumour that showed no amplification in the corresponding DNA (RQ=1.84) and two tumours, reported as HER2 negative by IHC, that showed amplification in microdissected foci of tumour cells (RQ values of 2.31 and 2.22, respectively). Here, ERBB2 is linked to neoplasm.